Stock Traders Purchase Large Volume of Call Options on Aemetis (NASDAQ:AMTX)

Key Points

• Unusual options activity: Traders purchased 6,674 Aemetis call options, approximately 316% above the average volume of 1,605 contracts.
• Stock and financial performance: Aemetis shares rose $0.15 to $1.95, while the company reported a quarterly loss of $0.13 per share—better than the expected $0.29 loss—but revenue of $62.7 million missed estimates.
• Mixed analyst sentiment: Aemetis has a consensus “Hold” rating, with one analyst recommending Buy and another Sell; the average price target is $11.88. Institutional investors own 27.02% of the company.

Aemetis, Inc (NASDAQ:AMTX - Get Free Report) saw some unusual options trading on Monday. Traders purchased 6,674 call options on the company. This is an increase of approximately 316% compared to the average volume of 1,605 call options.

Aemetis Price Performance

Shares of Aemetis stock traded up $0.15 during trading on Monday, hitting $1.95. 630,572 shares of the stock were exchanged, compared to its average volume of 1,253,871. The firm's 50-day moving average price is $1.79 and its 200 day moving average price is $2.15. The stock has a market cap of $140.37 million, a price-to-earnings ratio of -2.14 and a beta of 1.47. Aemetis has a 12-month low of $1.30 and a 12-month high of $3.80.

Aemetis (NASDAQ:AMTX - Get Free Report) last posted its earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.16. The business had revenue of $62.70 million during the quarter, compared to analysts' expectations of $67.69 million. As a group, research analysts forecast that Aemetis will post -0.89 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Royal Bank of Canada increased its stake in Aemetis by 10,632.5% in the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company's stock valued at $28,000 after purchasing an additional 8,825 shares during the last quarter. Sanctuary Advisors LLC purchased a new stake in shares of Aemetis during the 1st quarter worth approximately $33,000. Prairiewood Capital LLC acquired a new position in shares of Aemetis in the 1st quarter valued at $47,000. Patriot Financial Group Insurance Agency LLC acquired a new position in shares of Aemetis in the 1st quarter valued at $117,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Aemetis in the 4th quarter valued at $115,000. Hedge funds and other institutional investors own 27.02% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on AMTX. Weiss Ratings reissued a "sell (e+)" rating on shares of Aemetis in a research report on Friday, July 17th. Wall Street Zen raised shares of Aemetis from a "sell" rating to a "hold" rating in a report on Saturday, August 22nd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $11.88.

About Aemetis

Aemetis, Inc is a renewable fuels and biochemicals company focused on developing and operating technologies that reduce greenhouse gas emissions. Its activities include the production of renewable natural gas, renewable fuels, and other low-carbon products derived from agricultural and organic waste.

The company's Aemetis Biogas business develops and operates dairy-waste digesters and related infrastructure in California's Central Valley. These systems capture methane from dairy manure and convert it into renewable natural gas for transportation and other energy applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.